- Home
- CMPX vs CLPT Comparison
CMPX vs CLPT Comparison
Compare CMPX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- CLPT
- Stock Information
- Founded
- CMPX 2014
- CLPT 1998
- Country
- CMPX United States
- CLPT United States
- Employees
- CMPX N/A
- CLPT N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- CMPX Health Care
- CLPT Health Care
- Exchange
- CMPX Nasdaq
- CLPT Nasdaq
- Market Cap
- CMPX 408.6M
- CLPT 370.5M
- IPO Year
- CMPX N/A
- CLPT N/A
- Fundamental
- Price
- CMPX $1.95
- CLPT $11.87
- Analyst Decision
- CMPX Strong Buy
- CLPT Strong Buy
- Analyst Count
- CMPX 7
- CLPT 2
- Target Price
- CMPX $12.43
- CLPT $25.00
- AVG Volume (30 Days)
- CMPX 850.8K
- CLPT 229.6K
- Earning Date
- CMPX 05-12-2025
- CLPT 05-06-2025
- Dividend Yield
- CMPX N/A
- CLPT N/A
- EPS Growth
- CMPX N/A
- CLPT N/A
- EPS
- CMPX N/A
- CLPT N/A
- Revenue
- CMPX $850,000.00
- CLPT $31,390,000.00
- Revenue This Year
- CMPX $47.65
- CLPT $24.28
- Revenue Next Year
- CMPX $3,909.48
- CLPT $42.11
- P/E Ratio
- CMPX N/A
- CLPT N/A
- Revenue Growth
- CMPX N/A
- CLPT 31.04
- 52 Week Low
- CMPX $0.77
- CLPT $5.11
- 52 Week High
- CMPX $4.08
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- CMPX 31.88
- CLPT 34.87
- Support Level
- CMPX $2.18
- CLPT $13.09
- Resistance Level
- CMPX $2.17
- CLPT $14.01
- Average True Range (ATR)
- CMPX 0.16
- CLPT 0.65
- MACD
- CMPX -0.03
- CLPT -0.01
- Stochastic Oscillator
- CMPX 14.60
- CLPT 24.30
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.